BCI (Brain-Computer Interface) Weekly Report (August 6 - August 16, 2026)

This report covers brain-computer interface (BCI) news confirmed over 240 hours, from 9:55 AM on August 6, 2026 to 9:55 AM on August 16, 2026, Korea time. A BCI is a device that reads brain signals or stimulates the brain to control machines.

This week's news splits into China's national-level push of its BCI industry and, elsewhere, regulatory and non-invasive hardware news. Shanghai startup StairMed is developing an implant inserted into the brain through the jugular vein. The company says the procedure takes about 10 minutes, but so far it has only been tested on sheep. It is presented as an alternative to Elon Musk's Neuralink approach, which requires opening the skull. Over the past year, StairMed has raised 1.1 billion yuan (about $163 million), with investors including funds affiliated with Tencent and Alibaba. (South China Morning Post, August 9, 2026, https://www.scmp.com/business/companies/article/3363443/china-races-develop-brain-computer-interfaces-can-be-inserted-10-minutes)

Shanghai-based NeuraClear Medical Technology received approval from China's National Medical Products Administration (NMPA) to commercially sell its implantable BCI, "Neural Electronic Opportunity." The South China Morning Post reported this is the world's first implantable BCI sold commercially outside clinical trials. The same article reported that the Chinese government has set a goal of nurturing two to three globally competitive BCI companies by 2030. It also noted a forecast that the US BCI implant device market alone will grow to $80 billion by 2035. (South China Morning Post, August 13, 2026, https://www.scmp.com/business/china-business/article/3363799/chinas-brain-chip-drive-accelerates-slew-state-backed-initiatives)

The Korea Institute of Science and Technology (KIST) announced it has developed a next-generation BCI chip that reads electrical and optical signals together on a single chip. The chip packs 416 electrodes and 832 photosensor pixels across 13 silicon probes. KIST explains that combining standard semiconductor processes with 3D-printing post-processing brought manufacturing costs down to about one-hundredth of previous levels. In mouse experiments, the chip captured brainwave changes tied to anesthesia depth and responses to visual stimuli, and one week after implantation, inflammation and motor function remained normal. KIST plans to use the technology for precise diagnosis and treatment of Parkinson's disease, dementia, and depression. (Science Times, August 7, 2026, https://news.google.com/rss/articles/CBMijwFBVV95cUxONkt0MmRJZnR4dFdXZElIcDRDN2t1MmxFa28xNVpKTUxLM1B5djBpQ3NmRTExeG9qYTBVU2htaDZpVGhaSW1KbHFTM1lDd01rOHU1aHF2WHpjQkZWYkNaNDlFb09tTWxfay04WnRRdlBWLVRndjc0Q01GOGpnMGFTeTZhbFotX1hEQUQ3c3JLaw?oc=5)

Tongji Hospital, affiliated with Huazhong University of Science and Technology, announced on August 13 that it has completed the first fully invasive BCI surgery in the Huazhong region. Surgeons implanted eight ultra-thin electrode threads into the motor cortex of a 55-year-old patient. The system reads intentions such as raising a hand or walking to operate a robotic arm, wheelchair, computer cursor, and smart home devices, and is also planned for use in closed-loop rehabilitation training. It is described as China's first high-throughput, single-neuron-level BCI product, designated an innovative medical device by the NMPA. The report comes from a Chinese state news agency, and no independent clinical trial registration or third-party verification has been confirmed. (China News Service, August 13, 2026, https://www.chinanews.com.cn/sh/2026/08-13/10677063.shtml)

Non-invasive approaches are also moving in several directions. US startup Subsense is preparing a method that sprays billions of nanoparticles smaller than 100 nanometers into the nose and guides them to specific brain regions using a magnetic field. The system reads signals to decode the movement intentions of ALS patients, and conversely, delivers stimulation to reduce Parkinson's tremors. The nanoparticles are designed to clear from the brain within two months, and can also be forcibly extracted using a magnetic field. Co-founder Tetiana Alexandrova said she expects human clinical trials in 2 to 2.5 years, and a consumer product in 6 to 7 years. (Inner Cosmos with David Eagleman podcast, August 11, 2026, " target="_blank" rel="noopener" style="color:#1e3a5f;text-decoration:underline;">)

Former film director Davis Alexander James founded Blackflow Reality to build a non-invasive BCI that combines EEG (brainwave) signals, augmented reality, and lucid-dream induction technology. It is presented as a non-invasive alternative to Neuralink's implantable approach, but the current prototype distinguishes only a few "types of thought." The company is still pre-revenue and is seeking neurotechnology lab partners and investors. Beyond the founder's own account, no independent data confirming performance could be found. (Produck Podcast, August 10, 2026, " target="_blank" rel="noopener" style="color:#1e3a5f;text-decoration:underline;">)

Zhuhai, China-based Suiren Medical Technology introduced a smart pillow called "DreamLink" that reads brainwaves from the occipital lobe at the back of the head. It delivers sound, ocean-wave-like pulses, scent, and transcranial electrical stimulation timed to sleep stages. The presenter said slow-wave spindle intensity increased by about 30% and deep sleep stages increased by about 8%, but these are figures self-reported by the developer. (SSA 2026 conference presentation, August 10, 2026, " target="_blank" rel="noopener" style="color:#1e3a5f;text-decoration:underline;">)

In California, a bill restricting how companies can use workers' brain data passed the state Assembly and moved to Senate deliberation. A separate bill blocking the sale of brain data is also under discussion alongside it. California previously extended its digital privacy law to cover brain data two years ago. The background is concern over companies linking brain sensors, implants, and algorithms to monitor worker fatigue and predict productivity. (CalMatters, published via Almanac News, August 10, 2026, https://www.almanacnews.com/calmatters/2026/08/10/would-you-trust-your-boss-with-data-about-your-brain-california-moves-to-regulate-neurotech/)

The Zhejiang provincial government announced 18 support measures linking the BCI industry with academia and research institutions, taking effect September 10. Pre-clinical research will receive up to 8 million yuan in support per product. Review periods for Class II BCI medical devices will be cut to under 40 business days. The province has set a goal of growing BCI-related future-industry revenue to over 5 billion yuan by 2027, and also announced a goal of building an internationally competitive BCI innovation hub by 2030. (Xinhua News Agency, Zhejiang bureau, August 13, 2026, http://www.zj.xinhuanet.com/20260813/3da97407f1bd4871860b6381a1e3abcf/c.html)

On the academic side, ethics discussions are deepening. A paper published in Frontiers in Human Neuroscience points out that BCI ethics in mental health have been treated separately under the categories of autonomy, identity, and privacy. It proposes a new framework that ties these together around three axes: ethics, efficiency, and effectiveness. The paper cites UNESCO's 2025 recommendation on neurotechnology ethics as a milestone in international norms. (Chandra, Ramaprasad, Rangaswamy, Frontiers in Human Neuroscience, August 11, 2026, https://www.frontiersin.org/articles/10.3389/fnhum.2026.1846283/full)

Researchers at the University of Hong Kong, in a preprint posted on Research Square, examine a hypothetical case in which a speech BCI, through AI-refined sentences, is used to express that a fully paralyzed (locked-in) patient wishes to pursue assisted dying. They propose a "hybrid agency" framework that distinguishes "confirmatory elaboration," which aligns with values the patient previously expressed, from "generative substitution," which does not. This is a preprint that has not yet undergone peer review, and the case it discusses is hypothetical rather than an actual case. (Hok Lam Lee, Olivia M. Y. Ngan, Research Square preprint, August 10, 2026, https://doi.org/10.21203/rs.3.rs-10510331/v1)

Zhejiang's support measures actually take effect on September 10. How the two bills fare in the California Senate is the next thing to watch. China's stated 2027 core-technology roadmap and 2030 corporate-growth targets serve as benchmarks for judging how well this week's figures hold up going forward. Both StairMed's jugular-vein insertion method and Subsense's nasally sprayed nanoparticles remain at the animal-testing stage, and the timing of their transition to human clinical trials is the next point to watch.

This investigation was conducted across seven languages: English, Chinese, Korean, French, German, Swedish, and Russian. No independently reported BCI articles were found in Swedish or German. Articles found in those two languages were either reposts that simply carried over the StairMed article, or unrelated pieces using the acronym "BCI" in a different sense (a stock index or a fitness device).